Kantonsspital St.Gallen

CCX_Chemocentryx CL010 CCX168 (Avacopan)

Carina Hutz, Mira Bartz Batliner, Andrea Rubbert Roth & Thomas Neumann

abstract A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study
to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in
Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-
Associated Vasculitis Treated Concomitantly with Rituximab or
type of project clinical studies
status completed
start of project 2017
end of project 2021
responsible person PD Dr. med Thomas Neumann